Why the study?
Mutations in the TTN gene are the most common causes of dilated cardiomyopathy, but their clinical significance remains inadequately understood.
Does the presence of TTN truncating variants affect the risk of cardiac death or heart transplantation in patients with sporadic dilated cardiomyopathy?
Population
1,041 patients with sporadic DCM
Comparison
Patients with TTN truncating variants vs those without or with mutations in other known causal genes
Design
Prospective cohort study
Follow-up
Median of 44 months
Authors
Loading...
TTN truncating variants were not linked to higher event risk in sporadic DCM; leaves open their value in risk stratification.
Does the presence of TTN truncating variants affect the risk of cardiac death or heart transplantation in patients with sporadic dilated cardiomyopathy?
In patients with sporadic dilated cardiomyopathy, TTN truncating variants are common but do not significantly worsen the risk of cardiac death or heart transplantation compared to other genetic or non-genetic causes.
Xiao et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: